Reduction in hypochondriasis with treatment of panic disorder.
Hypochondriasis was assessed in 60 patients with panic disorder and agoraphobia using the Illness Behavior Questionnaire. Before treatment, IBQ hypochondriasis scores were similar to those of a group of hypochondriacal psychiatric patients. In patients who improved with treatment, significant reductions in somatic preoccupation, disease phobia, and disease conviction occurred. Hypochondriasis appears to be a prominent feature of panic disorder and agoraphobia, and responds to treatment of the primary conditions. Our findings underscore the importance of providing adequate treatment and thereby avoiding wasteful use of medical resources and alienation of patients from doctors.
D000328:Adult; D000379:Agoraphobia / Q000150:complications / Q000188:drug therapy*; D000525:Alprazolam / Q000627:therapeutic use*; D005239:Fear / Q000187:drug effects*; D006801:Humans; D006998:Hypochondriasis / Q000517:prevention & control*; D010200:Panic / Q000187:drug effects*; D010698:Phobic Disorders / Q000188:drug therapy*; D012803:Sick Role
D000525:Alprazolam